Samantha C. Gouw, MD, PhD received her PhD doctorate on the etiology of inhibitor development in children with severe hemophilia A (Utrecht University in 2011). In collaboration with a team of international colleagues, she published several papers in Blood and a paper in New England Journal of Medicine on genetic and non-genetic risk factors of inhibitor development. She trained as a pediatric hematologist and clinical epidemiologist. She currently works at the Department of Pediatric Hematology at the Amsterdam University Medical Center and as the coordinating researcher of a nationwide study in hemophilia patients at the Department of Clinical Epidemiology at Leiden University Medical center, The Netherlands. Her current research focuses on inhibitor development in hemophilia and the quality of hemophilia care.